Loading provider…
Loading provider…
Rheumatology Physician in Chicago, IL
NPI: 1649472440Primary Practice Location
THE UNIVERSITY OF CHICAGO MEDICAL CENTER
5700 S Maryland Ave, Chicago, IL
Primary Employer
University of Chicago
uchicagomedicine.org
HQ Phone
Get Kichul's Phone Numberphone_androidMobile
Get Kichul's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
IL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 113 | 176 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 47 | 81 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 33 | 33 |
| 4 | 20610Aspiration and/or injection of large joint or joint capsule | 15 | 24 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 15 | 15 |
Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis.
Authors: Emily Peninger, Charles Oshinsky
Journal: J Clin Invest
Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.
Authors: Timothy Niewold
Publication Date: 2012-04-17
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Intervention / Treatment: DRUG: Prednisone, DRUG: Mycophenolate Mofetil, DRUG: Hydroxychloroquine or Chloroquine
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib